• Most Popular
  • Most Shared

STOCKS NEWS EUROPE-Antisoma rises after cancer drug update

Fri May 15, 2009 4:56am EDT

Stocks

   

Shares in cancer specialist Antisoma (ASM.L) rise 3.3 percent to 31 pence after the company releases fresh data for its leukaemia drug AS1411 in the run up to the American Society of Clinical Oncology annual meeting at the end of May.

"We believe AS1411 continues to show encouraging safety and efficacy in relapsed/refractory acute myeloid leukaemia," say analysts at Piper Jaffray in a note to clients.

The broker has a "buy" recommendation on the stock and a target price of 81 pence.

Reuters messaging rm://ben.deighton.thomsonreuters.com@reuters.net


More from Reuters

A boy looks for recyclable items in the polluted waters of the Yamuna river in New Delhi December 9, 2009. REUTERS/Rupak De Chowdhuri

U.N. Climate Change Conference

Welcome to our live coverage of the U.N. Conference on Climate Change. This is your space to respond to our panalists and voice your views on the events at COP15.  Full Coverage 

    Discovery Communications Wellness Center medical technician Charline Faison notes patient medical information during an appointment at the clinic in the Discovery Communications headquarters buildingin Silver Spring, Maryland December 3, 2009. Credit: REUTERS/Jim Bourg

    House calls at the office

    Companies like Discovery say they've found a way to save millions in annual health insurance costs and provide better healthcare for their employees.  Full Article 

    Healthcare Reform
    Felix Salmon

    The banking revolution?

    A couple of firms you've probably never heard of have a few ideas that could revolutionize the broken consumer banking system, says Felix Salmon.  Full Article 

    Felix Salmon